Buluş, karaciğer kanserinde farmasotik Regorafenib ve Brigatinib ilaç kombinasyonunun sinerjistik sitotoksisitesi ile ilgilidir. TR 2021 020099 A2
This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.